Suppr超能文献

一名患有回结肠炎患者的惰性系统性肥大细胞增多症。

Indolent systemic mastocytosis in a patient with ileocolitis.

作者信息

Chrysakopoulos Georgios, Demonakou Maria, Papasavvas Stelios, Koutsoumpas Andreas, Mylonas Georgios, Tzias Vassilios

机构信息

Gastroenterology Department of 1 I.K.A. Hospital - Present address: Gastroenterology Clinic, General and Oncology Hospital of Kifissia Agioi Anargyroi (Georgios Chrysakopoulos, Stelios Papasavvas, Andreas Koutsoumpas, Georgios Mylonas, Vassilios Tzias), Athens, Greece.

Pathology Laboratory of G.H. Sismanoglion (Maria Demonakou), Athens, Greece.

出版信息

Ann Gastroenterol. 2014;27(3):270-272.

Abstract

Systemic mastocytosis is a clonal disorder of the mast cell and its progenitor cell. It is a rare disorder with unknown incidence in Greece, with an estimate of 2 cases per year in Great Britain. We present a case of an asymptomatic, 72-year-old man who was found to have ileocolitis on endoscopy. Histology revealed mast cells in lamina propria >15 HPF and biochemistry showed high levels of serum total tryptase. Molecular testing was positive for the mutation Asp816Val in exon 17 of . The patient met one major and two minor criteria for the diagnosis of systemic indolent mastocytosis (according to WHO classification). He has been treated prophylactically with H- and H-histamine receptor antagonists and remains asymptomatic.

摘要

系统性肥大细胞增多症是一种肥大细胞及其祖细胞的克隆性疾病。它是一种罕见疾病,在希腊发病率未知,据估计在英国每年有2例。我们报告一例72岁无症状男性病例,该患者在内镜检查时被发现患有回结肠炎症。组织学检查显示固有层每高倍视野(HPF)肥大细胞>15个,生化检查显示血清总类胰蛋白酶水平升高。分子检测显示某基因第17外显子Asp816Val突变呈阳性。该患者符合系统性惰性肥大细胞增多症诊断的一项主要标准和两项次要标准(根据世界卫生组织分类)。他接受了H1和H2组胺受体拮抗剂的预防性治疗,目前仍无症状。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/930b/4073030/b5640b234860/AnnGastroenterol-27-270-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验